Minerva Imaging

Minerva Imaging is a scientifically driven CRO and CDMO specializing in targeted radionuclide therapies, dedicated to accelerated and efficient drug development. With a focus on advanced models within oncology, cardiovascular diseases, and in vivo molecular imaging, Minerva Imaging excels in translational research and drug development. Minerva Imaging collaborates closely with clients to deeply understand their scientific objectives, tailoring its methods and capabilities to provide precise and insightful answers.

The company’s state-of-the-art facility, located at Lyshøjvej 21, Ølstykke, Capital Region 3650, DK, offers best-in-industry, fully integrated radiopharmaceutical research, drug development, and manufacturing services. Minerva Imaging is committed to innovation and excellence, continually pushing the boundaries of biotechnology to deliver superior results and contribute to groundbreaking advancements in healthcare.

Through its specialized services and commitment to scientific rigor, Minerva Imaging plays a crucial role in advancing the development of new therapies and improving patient outcomes. We invite the management team at Minerva Imaging to enhance your company’s presence on our platform by creating a customized and exclusive company showcase and product listing.